Despite higher operating revenues, UPMC reported a $371 million loss, attributing it to increased service demand and rising ...

Several obesity experts said perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications.

Some of what RFK Jr. says about obesity prevention isn't new. But after having coined the catchy MAHA acronym, it’s likely ...

While Ozempic bodes well for weight loss, some users are concerned the drug's impact also means unwanted changes to their ...

LANGHORNE, PA — Amplity Health shared valuable findings from its latest study on GLP-1 receptor agonist (GLP-1 RA) usage ...

If you're in a relationship that faces struggles with weight and are considering GLP-1 medications like Ozempic, consider ...

For employers wanting to dip a toe into the GLP-1 medications pool, utilization management is recommended to control costs.

For example, BlackRock reported that from 2019 to August 2023, GLP-1 prescription volumes increased at a compound annual ...

Ozempic — or any of the GLP-1 class of diet drugs that includes Wegovy and Mounjaro — hasn’t just changed our nation’s ...

For some, the issue with GLP-1 drugs like Ozempic and Mounjaro isn't getting access to these game-changing medications, but ...

StudyFinds' Dr. Faith Coleman explains what happens when patients stop taking popular weight loss medications.